ARTL Artelo Biosciences Inc.: יחס שווי פעילות להכנסות

לוגו של חברה ציבורית Artelo Biosciences Inc. (ARTL)

The stable operation of Artelo Biosciences contract manufacturing confirms the technological maturity of the business. The EV/Sales ratio clearly captures the company's market value relative to sales, where the indicator stands at 0.00. Leading biochemists, attracted by RSU options, drive this success. Furthermore, demand for cancer therapy remains independent of macroeconomics, rendering the company resilient to market cycles.

Artelo Biosciences, Inc. (ARTL): שווי חברה להכנסות מ-23.11.2025 עד 20.11.2026

Artelo Biosciences Inc. - פילוחים אנליטיים ומדדי מפתח (ARTL)

- מחיר ותחזית קונצנזוס למחירים:
ניתוח ראשוני של החברה:ARTL, Artelo
סחורת הדגל של Artelo Biosciences, Inc.

Artelo Biosciences strategic alliances in the cannabinoid sector define the company's EV/Revenue trajectory, reflecting market expectations for future M&A. This indicator compares the total Enterprise Value (EV), including debt and subtracting cash, with sales volume, allowing for an assessment of whether the asset is overvalued or undervalued regardless of the capital structure.